MedTrace Logo

Comparison of Body Weight Change Through Different Smeglutide Administration Methods

NCT05616052 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-11-15

No results posted yet for this study

Summary

Investigators determined to detect the effect of smeglutide on body weight and metabolic indexes among overweight and obese participants through two different dosing programs.

Conditions

  • Weight Change, Body

Interventions

DRUG

Semaglutide

treatment with different dosage regimes

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Principal Investigators

  • xiaolong zhao · Shanghai Public Health Clinical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05616052 on ClinicalTrials.gov